A detailed history of Readystate Asset Management LP transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Readystate Asset Management LP holds 186,902 shares of ITOS stock, worth $2.94 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
186,902
Previous 141,791 31.82%
Holding current value
$2.94 Million
Previous $1.55 Billion 64.2%
% of portfolio
0.04%
Previous 0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$9.89 - $13.64 $446,147 - $615,314
45,111 Added 31.82%
186,902 $2.55 Billion
Q4 2023

Feb 14, 2024

BUY
$8.57 - $11.06 $309,377 - $399,266
36,100 Added 34.16%
141,791 $1.55 Billion
Q3 2023

Nov 14, 2023

BUY
$10.95 - $14.6 $189,435 - $252,580
17,300 Added 19.57%
105,691 $1.16 Billion
Q2 2023

Aug 14, 2023

BUY
$12.93 - $18.05 $1.14 Million - $1.6 Million
88,391 New
88,391 $1.17 Billion

Others Institutions Holding ITOS

About iTeos Therapeutics, Inc.


  • Ticker ITOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,575,300
  • Market Cap $560M
  • Description
  • Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...
More about ITOS
Track This Portfolio

Track Readystate Asset Management LP Portfolio

Follow Readystate Asset Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Readystate Asset Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Readystate Asset Management LP with notifications on news.